The use of B-type natriuretic peptides in coronary artery disease: utile or futile?

-type natriuretic peptides (BNP and N-terminal [NT]roBNP) have been shown to be extremely helpful in the iagnosis, prognosis, and monitoring of therapy of patients ith heart failure (HF) (1). These neurohormones are preominately secreted from the left and the right cardiac ventricle n response to cardiac stress. The BNPs can be seen as uantitative markers of HF summarizing the extent of systolic nd diastolic left ventricular dysfunction, valvular dysfunction, nd right ventricular dysfunction (1).